ArticleMaterials today. Bio2025

Dual-targeted albumin nanoparticles for the Co-delivery of low-dose paclitaxel and PCSK9 inhibitor in melanoma treatment.

Ling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.